GeneDx to Report Second Quarter 2024 Financial Results on Tuesday, July 30, 2024
GeneDx to Report Second Quarter 2024 Financial Results on Tuesday, July 30, 2024
STAMFORD, Conn., July 11, 2024 (GLOBE NEWSWIRE) -- GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced it will release financial results for the second quarter of 2024 after the market closes on Tuesday, July 30, 2024. Management will host a conference call that day to discuss second quarter 2024 financial and operating results at 4:30 p.m. Eastern Time.
2024年7月11日康涅狄格州斯坦福（GLOBE NEWSWIRE）——GeneDx（纳斯达克：WGS）通过基因组洞见在提供改善健康结局方面处于领先地位，今天宣布将在2024年7月30日星期二美国东部时间下午4:30公布2024年第二季度财务业绩。当天，管理团队将主持电话会议，讨论2024年第二季度财务和运营业绩。
Conference Call Details
Investors interested in listening to the conference call are required to register online. A live and archived webcast of the event will be available on the "Events" section of the GeneDx investor relations website at .
电话会议详情
对于对电话会议感兴趣的投资者，需要在线进行注册。本次活动的现场直播和归档的网络广播将在GeneDx投资者关系网站的“事件”部分提供。.
About GeneDx
At GeneDx (Nasdaq: WGS), we believe that everyone deserves personalized, targeted medical care—and that it all begins with a genetic diagnosis. Fueled by one of the world's largest rare disease data sets, our industry-leading exome and genome tests translate complex genomic data into clinical answers that unlock personalized health plans, accelerate drug discovery, and improve health system efficiencies. It all starts with a single test. For more information, please visit genedx.com and connect with us on LinkedIn, X, Facebook, and Instagram.
关于GeneDx
在GeneDx（纳斯达克：WGS），我们相信每个人都应该享受个性化、有针对性的医疗保健，而这一切都始于基因诊断。在世界上最大的罕见病数据集之一的推动下，我们业界领先的外显子组和基因组检测将复杂的基因组数据转化为临床答案，揭示个性化的健康计划、加速药物研发并提高健康系统效率。一切都始于一项测试。欲了解更多信息，请访问genedx.com并与我们联系。LinkedIn, X, Facebook和Instagram.
Investor Relations Contact:
investors@GeneDx.com
投资者关系联系方式：
investors@GeneDx.com
Media Contact:
press@GeneDx.com
媒体联系人：
press@GeneDx.com